ARKG vs TECL

ARK Genomic Revolution ETF vs Direxion Daily Technology Bull 3X ETF

Quick take
  • • ARKG has the lower expense ratio at 0.75% vs 0.87% for TECL.
  • • TECL pays a higher dividend yield (0.17%).

Side-by-side metrics

MetricARKGTECL
Expense ratio
Annual fee. Lower is better.
0.75%0.87%
Dividend yield
Trailing 12-month yield.
0.00%0.17%
AUM
Assets under management — bigger funds are typically more liquid.
$2.21B$5.07B
YTD return
66.55%23.12%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.114.94
P/E ratio
—26.32
Last price
$47.17$156.80
Inception
——
Issuer
ARKDirexion

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp8.75%
TXG10x Genomics Inc Ordinary Shares - Class A8.73%
TEMTempus AI Inc Class A common stock8.36%
ABSIAbsci Corp5.56%
CRSPCRISPR Therapeutics AG5.22%
GHGuardant Health Inc4.88%
NTRANatera Inc4.71%
ILMNIllumina Inc4.69%
LLYEli Lilly and Co3.92%
BEAMBeam Therapeutics Inc3.69%
Sector breakdown · ARKG
Healthcare100.0%

TECL top holdings

Top holdings · TECL
AAPLApple Inc3.54%
NVDANVIDIA Corp3.48%
MSFTMicrosoft Corp2.73%
Sector breakdown · TECL
Technology100.0%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About TECL

TECL (Direxion Daily Technology Bull 3X ETF) is 3x daily performance of the S&P tech sector. Managed by Direxion, the fund carries $5.1B in assets under management, an expense ratio of 0.87%, a dividend yield of 0.17%. Its largest holding is Apple Inc (AAPL), which represents 3.5% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.